Editorial on the Research Topic
Microbiome-gut-brain axis crosstalk and clinical outcomes
Recently, intestinal microbiota is considered as a new and largest organ of the human body, with a total number of 1013-1014, ~10 times the number of human cells. The total number of bacterial genes encoded is 150 times the total number of human genes, known as the “second genome” of humans, and plays an important role in maintaining human health. It is a direct connection between external environment and human body. However, due to the existence of a blood-brain barrier between the central nervous system and the periphery, there is controversy over whether early gut microbiota affects brain function and diseases, resulting in research lagging behind other systemic diseases.
In recent years, an increasing number of studies have shown that gut microbiota disorders are closely related to various mental illnesses, including depression, bipolar disorder, schizophrenia, autism, attention deficit hyperactivity disorder, and substance related disorders. In 2012, Professor John F. Cryan and others from the University of Cork in Ireland emphasized the important role of Microbiome-Gut-Brain Axis (MGB). The gut microbiota can affect brain function and behavior through microbial derived metabolites, cytokines, immunity, vagus nerve pathways, and other pathways. The proposal of this concept not only enriches and develops the previous brain gut microbiota axis, but also provides a new entry point for revealing the pathogenesis of mental illness and exploring new diagnostic and treatment strategies.
This Research Topic “Microbiome-gut-brain axis crosstalk and clinical outcomes” takes advantage of the Frontiers publishing concept to advance communication among neuroscientists, microbiologist, geneticist, nutritionists, clinicians, psychiatrists, and psychologists with unique experience and skills, to fulfill the puzzle of host-microbiome interaction that contribute to health brain: introduces the correlation and possible mechanisms between gut microbiota disorders and the onset of various mental illnesses, as well as clinical and basic research on improving mental illnesses by regulating gut microbiota, in order to provide new directions for the etiology and diagnosis and treatment of mental illnesses.
In our topic, Murray et al. “Demonstrating a link between diet, gut microbiota and brain: 14C radioactivity identified in the brain following gut microbial fermentation of 14C-radiolabeled tyrosine in a pig model”, it proof that amino acids released from resistant protein following gut microbial fermentation, would be bioavailable to the brain (Figure 1). The original article “Bifidobacterium animalis subsp. lactis and arginine mixture intake improves cognitive flexibility in mice” by Ikuta et al., is the first report to show that probiotics consisting of Bifidobacterium animalis subsp. lactis and arginine (Bifal + Arg), improves cognitive flexibility in mice (Figure 2). A systematic review “Potential neuroprotective effects of fermented foods and beverages in old age: a systematic review” by Porras-García et al. also summarized the existing studies to establish whether the consumption of fermented foods and fermented beverages prevents or ameliorates neurodegenerative decline in old age. Overall, the evidence obtained in these articles not only enriches and develops the previous brain gut microbiota axis, but also provides a new technic for revealing the pathogenesis of mental illness and exploring new diagnostic and treatment strategies.
Author contributions
XZ: Writing—original draft, Writing—review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: microbiome, gut, brain, MGB, clinical application, neuropsychiatric disease
Citation: Zhang X (2024) Editorial: Microbiome-gut-brain axis crosstalk and clinical outcomes. Front. Nutr. 11:1358659. doi: 10.3389/fnut.2024.1358659
Received: 20 December 2023; Accepted: 15 January 2024;
Published: 12 February 2024.
Edited and reviewed by: Ramón Sotomayor-Zárate, Universidad de Valparaiso, Chile
Copyright © 2024 Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaojie Zhang, eGlhb2ppZXpoYW5nMjAxNCYjeDAwMDQwO2NzdS5lZHUuY24=